Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Myokardinfarkt

  • Chapter
Intensivmedizin

  • 39 Accesses

Zusammenfassung

In der BRD sterben jährlich über 80000 Menschen an einem Herzinfarkt. Bei mehr als der Hälfte der Patienten mit akutem Myokardinfarkt tritt der Tod in der 1. Stunde nach dem Infarkt ein, bedingt durch deletäre Herzrhythmusstörungen (meistens Kammernflimmern). Seit den 70er Jahren hat die Krankenhausmortalität des akuten Myokardinfarkts aus verschiedenen Gründen von 20–30% auf jetzt 10–15% abgenommen [1]. Von wesentlicher Bedeutung sind die Einrichtung von Intensivstationen, die Verbesserung der Überwachung und Reanimation in der Prähospital-Phase sowie neuere mechanische und medikamentöse Therapieverfahren. Diese Faktoren haben dazu beigetragen, daß Herzrhythmusstörungen als Todesursache im Verlauf des Myokardinfarktes ganz in den Hintergrund getreten sind, während die Linksherzinsuffizienz und der kardiogene Schock nunmehr eine herausragende Rolle spielen.

Die Textabschnitte 10.1–10.3 wurden von F.V. Kohl verfaßt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. AIMS Trial Study Group (1988) Effect of intravenous APSAC after acute myocardial infarction: Preliminary report of a placebo-controlled clinical trial. Lancet I: 545–549

    Google Scholar 

  2. Becker LC, Ambrosio G (1987) Myocardial consequences of reperfusion. Progr Cardiovasc Dis 30: 23–44

    Article  CAS  Google Scholar 

  3. Braunwald E (1988) Thrombolytic reperfusion of acute myocardial infarction: Resolved and unresolved issues. J Am Coll Cardiol 12: 85A- 92A

    Google Scholar 

  4. Cerecek B, Lew AS, Hod H et al. (1986) Enhancement of thrombolysis with tissue-type plasminogen activator by pretreatment with heparin. Circulation 74: 583–587

    Article  Google Scholar 

  5. Chandler AB, Chapmann I, Erhardt LR et al. (1974) Coronary thrombosis in myocardial infarction. Report of a workshop on the role of coronary thrombosis in the pathogenesis of acute myocardial infarction. Am J Cardiol 34: 823–833

    Article  PubMed  CAS  Google Scholar 

  6. Chin WDN, Cheung HW, Driedger AA et al. (1985) Assisted ventilation in patients with preexisting cardiopulmonary disease. The effect on systemic oxygen consumption, oxygen transport, and tissue perfusion variables. Chest 88: 503–511

    CAS  Google Scholar 

  7. De Wood MA, Spoires J, Notske R et al. (1980) Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 303: 897–902

    Article  Google Scholar 

  8. De Munk GAW, Rijken DC (1990) Fibrinolytic properties of single chain urokinase-type plasminogen activator ( Pro-urokinase ). Fibrinolysis 4: 1–9

    Google Scholar 

  9. De Feyter PJ, Brand M van den, Serruys PW, Wijns W (1985) Early angiography after myocardial infarction: What have we learned? Am Heart J 109: 194–199

    Article  PubMed  Google Scholar 

  10. Diefenbach C, Erbel R, Pop T et al. (1988) Recombinant single-chain urokinase-type plasminogen activator during acute myocardial infarction. Am J Cardiol 61: 966–970

    Article  PubMed  CAS  Google Scholar 

  11. Gold HK, Leinbach RC, Garabedian HD et al. (1986) Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. Circulation 73: 347–352

    Article  PubMed  CAS  Google Scholar 

  12. Grines CL, DeMaria AD (1990) Optimal utilization of thrombolytic therapy for acute myocardial infarction: Concepts and controversies. J Am Coll Cardiol 16: 223–231

    Article  PubMed  CAS  Google Scholar 

  13. Gruppo Italiano per lo studio della streptochinasi nell’infarto miocardico (GISSI) (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet I: 397–402

    Google Scholar 

  14. Hevroy O, Reikeras O, Grundnes O, Mjos OD (1988) Cardiovascular effects of positive end expiratory pressure during acute left ventricular failure in dogs. Clin Physiol 8: 287–301

    Article  PubMed  CAS  Google Scholar 

  15. ISIS-2 (Second International Study of Infarct Survival) collaborative Group (1988) Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet I: 349–360

    Google Scholar 

  16. Killip T, Kimball JT (1967) Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 20: 457–462

    Article  PubMed  Google Scholar 

  17. Kohl FV, Wiehert P von (1990) Beatmung and akuter Myokardinfarkt. Intensivmed 27: 120–123

    Google Scholar 

  18. a.Kohl FV (1991) Beatmung beim herzkranken Patienten. Internist 32: 199–205

    PubMed  CAS  Google Scholar 

  19. Loscalzo J, Braunwald E (1988) Tissue plasminogen activator. N Engl J Med 319: 925–931

    Article  PubMed  CAS  Google Scholar 

  20. Mac Mahon S, Collins R, Peto R et al. (1988) Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from randomized, controlled trials. JAMA 260: 1910–1916

    Google Scholar 

  21. Manz M, Wagner WL, Luderitz B (1987) Differentialindikation zur antiarrhythmischen Therapie. Internist 28: 182–189

    PubMed  CAS  Google Scholar 

  22. Marder VJ, Sherry S (1988) Thrombolytic therapy: current status ( First of two parts ). N Engl J Med 318: 1512–1520

    Article  PubMed  CAS  Google Scholar 

  23. Marder VJ, Sherry S (1988) Thrombolytic therapy: current status ( Second of two parts ). N Engl J Med 318: 1585–1595

    Article  PubMed  CAS  Google Scholar 

  24. Neuhaus KL, Tebbe U, Gottwik M et al. (1988) Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: Results of the German Activator Urokinase Study ( GAUS ). J Am Coll Cardiol 12: 581–587

    Article  PubMed  CAS  Google Scholar 

  25. Neuhaus KL, Feuerer W, Jeep Tebbe S et al. (1989) Improved thrombolysis with a modified regimen of recombinant tissue-type plasminogen activator. J Am Coll Cardiol 14: 1566–1569

    Article  PubMed  CAS  Google Scholar 

  26. Norris RM, Singh BN (1982) Arrhythmias in acute myocardial infarction. In: Norris RM (ed) Myocardial infarction. Its presentation, pathogenesis and treatment. Edinburgh, Churchill Livingstone

    Google Scholar 

  27. O’Neill WW, Topol EJ, Pitt B (1988) Reperfusion therapy of acute myocardial infarction. Progr Cardiovasc Dis 30: 235–266

    Article  Google Scholar 

  28. Ohman EM, Califf RM (1990) Thrombolytic therapy: overview of clinical trials. Coronary Artery Disease 1: 23–33

    Article  Google Scholar 

  29. Passamani E, Hodges M, Herman M et al. for the TIMI Investigators (1987) The thrombolysis in myocardial infarction (TIMI) phase II pilot study: Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 10: 51B- 64B

    Google Scholar 

  30. PRIMI Trial Study Group (1989) Randomised double-blind trial of recombinant pro-urokinase against streptokinase in acute myocardial infarction. Lancet I: 863–868

    Google Scholar 

  31. Räsänen J, Vaisanen IT, Heikkila J, Nikki P (1985) Acute myocardial infarction complicated by left ventricular dysfunction and respiratory failure. The effects of continuous positive airway pressure. Chest 87: 158–162

    Article  PubMed  Google Scholar 

  32. Report of the American College of Cardiology/American Heart Association task forces on assessment of diagnostic and therapeutic cardiovascular procedures (1989) Guidelines for clinical intracardiac electrophysiologic studies. Circulation 80: 1925–1939

    Article  Google Scholar 

  33. Rogers WJ, Bairn DS, Gore JM et al. (1990) Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction ( TIMI) Phase II-A Trial. Circulation 81: 1457–1476

    Article  PubMed  CAS  Google Scholar 

  34. Schaper W, Görge G, Winkler B, Schaper J (1988) The collateral circulation of the heart. Progr Cardiovasc Diseas 31: 57–77

    Article  CAS  Google Scholar 

  35. Scholz KH, Hermann C, Tebbe U et al. (1988) Riick- 48. gang der Krankenhaus-Sterblichkeit am akuten Myokardinfarkt während der letzten zehn Jahre. Effekt der Akutintervention? Dtsch Med Wochenschr 113: 49. 1305–1311

    Article  PubMed  CAS  Google Scholar 

  36. Scholz KH, Saathoff H, Tebbe U (1989) Intraaortale Bollongegenpulsation bei akutem Myokardinfarkt, 50. ischämischer Linksherzinsuffizienz and therapierefraktärer Angina pectoris. Dtsch Med Wochenschr 114: 51. 1821–1827

    Article  PubMed  CAS  Google Scholar 

  37. Schröder R, Neuhaus KL, Leizorovicz A et al. for the ISAM Study Group (1986) A prospective trial of intrave- 52. nous streptokinase in acute myocardial infarction (ISAM). Mortality, morbidity, and infarct size at 21 days. N Engl J Med 314: 1465–1471

    Google Scholar 

  38. Schröder R (1989) Thrombolyse bei akutem Myokardin- 53. farkt: Eine Standortbestimmung 1988. Z Kardiol 78: 41–62

    PubMed  Google Scholar 

  39. Seipel L (1988) Kardiale Nebenwirkungen von Antiarrhythmika. Z Kardiol 77: 77–88

    PubMed  CAS  Google Scholar 

  40. Seipel L (1989) Therapie der ventrikulären Extrasystolie. Dtsch Med Wochenschr 114: 1571–1575 54.

    Google Scholar 

  41. Simoons ML, Arnold AER, Betriu A et al. for the European Cooperative Study Group (1988) Thrombolysis 55. with tissue plasminogen activator in acute myocardial infarction: No additional benefit from immediate percutaneous coronary angioplasty. Lancet I: 197–203

    Google Scholar 

  42. Sleight P (1990) Do we need to intervene after thrombo- 56. lysis in acute myocardial infarction? Circulation 81: 1707–1709

    Article  PubMed  CAS  Google Scholar 

  43. Smith P, Arnesen H, Holme I (1990) The effect of warfa- 57. rin on mortality and reinfarction after myocardial infarction. N Engl J Med 323: 147–152

    Article  PubMed  CAS  Google Scholar 

  44. Smith PK, Tyson Jr GS, Hammon JW Jr et al. (1982) Cardiovascular effects of ventilation with positive expiratory airway pressure. Ann Surg 195: 121–130 58.

    Google Scholar 

  45. Tebbe U, Tanswell P, Seifried E et al. (1989) Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarction. Am J Cardiol 64: 448–453 59.

    Google Scholar 

  46. TIMI Research Group (1988) Immediate versus delayed catheterization and angioplasty following thromobolytic therapy for acute myocardial infarction. TIMI II A results. J Am Med Ass 260: 2849–2858 60.

    Google Scholar 

  47. TIMI Study Group (1985) The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. N Engl J Med 312: 932–936

    Google Scholar 

  48. TIMI Study Group (1989) Comparison of invasive and 61. conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. N Engl J Med 320: 618–627

    Article  Google Scholar 

  49. Thompson JA, Hess ML (1986) The oxygen free radical system: A fundamental mechanism in the production of myocardial necrosis. Progr Cardiovasc Dis 28: 449–462

    Article  CAS  Google Scholar 

  50. Tiefenbrunn AJ, Sobel BE (1989) The impact of coronary thrombolysis on myocardial infarction. Fibrinolysis 3: 1–15

    Google Scholar 

  51. TIMI-Operations Committee (1987) Announcement of protocol change in TIMI trial. J Am Coll Cardiol 9: 467

    Google Scholar 

  52. Tittley JG, Stephen EF, Weisel RD et al. (1985) Hemodynamic and myocardial metabolic consequences of PEEP. Chest 88: 496–502

    Article  PubMed  CAS  Google Scholar 

  53. Topol EJ, George BS, Kereiakes DJ et al. and the TAMI Study Group (1988) Comparison of two dose regimens of intravenous tissue plasminogen acute myocardial infarction. Am J Cardiol 61: 723–728

    Google Scholar 

  54. Topol EJ, Califf RM, George BS et al. and the thrombolysis and angioplasty in myocardial infarction (TAMI) Study Group (1987) A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 317: 581–588

    Google Scholar 

  55. Verstraete M, Collen D (1986) Thrombolytic therapy in the eighties. Blood 67: 1529–1541

    PubMed  CAS  Google Scholar 

  56. Vincent JL, Suter PM (eds) (1987) Update in intensive care and emergency medicine. Cardiopulmonary interactions an acute respiratory failure. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  57. Wellens HJJ, Brugada P (1989) Treatment of cardiac arrhythmias: when, how and where? J Am Coll Cardiol 14: 1417–1428

    Article  PubMed  CAS  Google Scholar 

  58. Wilcox RG, Lippe G von der, Olsson CG et al. for the ASSET Study Group (1988) Trial of tissue plasminogen activator for mortalityreduction in actute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis ( ASSET ). Lancet I: 525–530

    Google Scholar 

  59. Yusuf S, Collins R, MacMahon S et al. (1988) Effect of iv nitrates on mortality in acute myocardial infarction: An overview of the randomized trials. Lancet I: 1088–1092

    Google Scholar 

  60. Yusuf S, Wittes J, Friedman L (1988) Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA 260: 2088–2093

    Article  PubMed  CAS  Google Scholar 

  61. Yusuf S, Wittes J, Friedman L (1988) Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA 260: 2259–2263

    Article  PubMed  CAS  Google Scholar 

  62. Yusuf S, Peto R, Lewis Jet al. (1985) Beta blockade during and after myocardial infarction: An overview of the randomized trials. Progr Cardiovasc Dis 27: 335–371

    Article  CAS  Google Scholar 

Download references

Authors
  1. U. Tebbe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Univ.-Klinik für Anästhesie und Allgemeine Intensivmedizin, Univ. Innsbruck, Anichstr. 35, A-6020, Innsbruck, Österreich

    Herbert Benzer

  2. Zentrum Anästhesiologie, Rettungs- und Intensivmedizin, Universität Göttingen, Robert-Koch-Str. 40, D-3400, Göttingen, Deutschland

    H. Burchardi

  3. Klinik für Anästhesiologie und Intensivmedizin, Universitätskliniken des Saarlands, D-6650, Homburg/Saar, Deutschland

    Reinhard Larsen

  4. Div. des Soins Intensifs Chirurgicaux, Département d’Anesthésiologie, Hôpital Cantonal Universitaire, CH-1211, Genève 14, Schweiz

    Peter M. Suter

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Tebbe, U. (1993). Myokardinfarkt. In: Benzer, H., Burchardi, H., Larsen, R., Suter, P.M. (eds) Intensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97183-9_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-97183-9_30

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-97184-6

  • Online ISBN: 978-3-642-97183-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation